Skip to main content
. 2021 Aug 2;5(8):e617. doi: 10.1097/HS9.0000000000000617

Figure 1.

Figure 1.

Disposition of patients included in the final analysis. AEs = adverse events; AML = acute myeloid leukemia; LDAC = low-dose cytarabine; MDS = myelodysplastic syndrome; RAEB = refractory anemia with excess blasts.